The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Mineralys Therapeutics Inc (NASDAQ: MLYS) closed at $13.45 down -6.08% from its previous closing price of $14.32. In other words, the price has decreased by -$6.08 from its previous closing price. On the day, 1.05 million shares were traded.
Ratios:
For a deeper understanding of Mineralys Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.48 and its Current Ratio is at 26.48. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on June 11, 2025, initiated with a Hold rating and assigned the stock a target price of $15.
On July 10, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.
On April 02, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $30.Goldman initiated its Buy rating on April 02, 2024, with a $30 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’25 when Rodman David Malcom sold 11,366 shares for $14.60 per share. The transaction valued at 165,931 led to the insider holds 101,651 shares of the business.
Rodman David Malcom bought 11,366 shares of MLYS for $165,931 on Jun 13 ’25. On May 14 ’25, another insider, Rodman David Malcom, who serves as the Chief Medical Officer of the company, sold 11,366 shares for $15.29 each. As a result, the insider received 173,774 and left with 106,669 shares of the company.
Stock Price History:
Over the past 52 weeks, MLYS has reached a high of $18.38, while it has fallen to a 52-week low of $8.24. The 50-Day Moving Average of the stock is -8.21%, while the 200-Day Moving Average is calculated to be 4.51%.
Shares Statistics:
A total of 64.88M shares are outstanding, with a floating share count of 40.60M. Insiders hold about 37.70% of the company’s shares, while institutions hold 65.21% stake in the company.
